1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

AML - 792

Treatment Patterns and Outcomes with Olutasidenib After Venetoclax in IDH1-Mutated AML Using Real-World Data from Chart Review

Amber Thomasson

Poster Presenter: Amber Thomasson

Thumbnail for Efficacy and Safety of Venetoclax Combined with Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

AML - 806

Efficacy and Safety of Venetoclax Combined with Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

Thumbnail for Optimizing Low-Intensity Therapeutic Strategies in Older Acute Myeloid Leukemia: A Systematic Review and Network Meta-Analysis

AML - 811

Optimizing Low-Intensity Therapeutic Strategies in Older Acute Myeloid Leukemia: A Systematic Review and Network Meta-Analysis

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

Thumbnail for ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

AML - 828

ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

Archit Goel

Poster Presenter: Archit Goel

AML - 829

Comparison of Ivosidenib- and Venetoclax-Based Treatment Sequencing and Outcomes in Patients With mIDH1 AML: A Real-World Study

Vanessa Kennedy

Poster Presenter: Vanessa Kennedy

Thumbnail for All-Oral Treatment in Patients Older Than 65 Years With Newly Diagnosed Acute Myelogenous Leukemia: Progression-Free Survival and Toxicity

AML - 843

All-Oral Treatment in Patients Older Than 65 Years With Newly Diagnosed Acute Myelogenous Leukemia: Progression-Free Survival and Toxicity

Maher Salamoon

Poster Presenter: Maher Salamoon

$Thumbnail for Efficacy and Differentiation Syndrome With Menin Inhibitors in Relapsed/Refractory KMT2A-Rearranged or NPM1-Mutated Acute Leukemia: An Exploratory Proportional Meta-Analysis$

AML - 848

Efficacy and Differentiation Syndrome With Menin Inhibitors in Relapsed/Refractory KMT2A-Rearranged or NPM1-Mutated Acute Leukemia: An Exploratory Proportional Meta-Analysis

Farzeen Fatma Syed

Poster Presenter: Farzeen Fatma Syed

Thumbnail for Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

AML - 849

Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

AML - 851

FIRST-LINE TREATMENT OUTCOMES IN TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Ali Mohamedi

Poster Presenter: Ali Mohamedi